Purpose The purpose of our study was to assess 18 F–DCFBC PET/CT, a PSMA targeted
PET agent, for lesion detection and clinical management of biochemical relapse in prostate …

The purpose of this study was to compare the diagnostic performance of 18 F-DCFBC PET/CT,
a first-generation 18 F-labeled prostate-specific membrane antigen (PSMA)–targeted …

Objective: The aim of this study was to evaluate the impact on pediatric care of the Pacific
Asynchronous TeleHealth (PATH) system, a provider-to-provider teleconsultation platform …

18 F-DCFPyL, 18 F-sodium fluoride ( 18 F-NaF), and 18 F-FDG PET/CT were compared in a
prospective cohort of men with metastatic prostate cancer (PCa). Methods: Sixty-seven men (…

Mantle cell lymphoma (MCL) is biologically and clinically heterogeneous and would benefit
from prognostic biomarkers to guide management. Circulating tumor DNA (ctDNA) is a novel …

Purpose Prostate-Specific Membrane Antigen (PSMA) PET/CT has been introduced as a
sensitive method for characterizing metastatic prostate cancer. The purpose of this study is to …

Background: Foundational studies have revealed essential oncogenic pathways in DLBCL,
triggering the development of drugs targeting distinct survival pathways in this malignancy. …

Introduction Frontline therapy for pts with follicular lymphoma (FL) is not based on the molecular
profile of the tumor. The PI3K pathway is central to FL biology, but the molecular profile …

707 Objectives: To assess the clinical impact of 18F-DCFBC PET/CT, a PSMA targeted PET
agent, for lesion detection and clinical management of biochemical relapse prostate cancer …

1322 Introduction: Lesion detection in men with biochemically recurrent prostate cancer (BCR)
can be both challenging and important in deciding management options, especially at …